H 2008 20034.4% 200810.8% 20030.1%20086.1% 20062007200812312009531 5% 2006 2007200812312009531 5% 2003200816% 20092011 8,500 2007 1.12,300 200312.7% 200820.0% 19 105
25 200880% 200953136.4% 56.2%24,000 2009531.............................................................. 4,723........................................................ 2,545............................................... 22,155 200953122,000 3,3003050 RocheAstraZenecaPfizerGlaxoSmithKlineMerckEli Lilly Novo Nordisk95 100 5046 90% 200623,736.62007 31,110.2200838,187.420062008 26.8%2006101.32007 380.92008585.720062008 140.4%200953118,048.02008 20.3%2009531 421.5200841.9% 106
200620072008 123120095312.0%2.5% 3.1%3.9%0.4%1.2%1.5%2.3% 2003 200810.8% 20092011 8,500 2007 1.12,300 200312.7%200820.0% 107
2003 1925 22,000 200953130 5095100 108
20066.4%20085.1%2009531 4.2%20062.0%20083.1%2009 5313.9%20060.4%20081.5% 20095312.3% 109
15 110
ERP 111
112
1231 531 2006 2007 2008 2008 2009 % % % % % (1)(2)............... 21,927.2 92.4 28,997.3 93.2 35,745.1 93.6 14,017.7 93.4 16,845.7 93.3............... 823.1 3.5 835.6 2.7 952.2 2.5 389.0 2.6 463.2 2.6............... 986.3 4.2 1,277.3 4.1 1,490.2 3.9 600.5 4.0 739.1 4.1............ 23,736.6 100.0 31,110.2 100.0 38,187.4 100.0 15,007.2 100.0 18,048.0 100.0 (1) (2) 2006200720081231177.6225.9 311.220082009531140.9 147.6 90% 1925 20095314,723 36.4%56.2% 90% 1960 (1) 113
200614(i) (ii) (iii)(iv)(v) (vi) (vii) 200620072008123120082009531 507,50054,970,00051,615,4007,200 1231 531 2006 2007 2008 2008 2009 % % % % %....................... 9,642.2 44.0 13,216.6 45.6 16,719.0 46.8 6,563.4 46.8 8,129.7 48.3................. 10,927.3 49.8 13,753.8 47.4 16,263.6 45.5 6,372.0 45.5 7,134.2 42.3........ 1,357.7 6.2 2,026.9 7.0 2,762.5 7.7 1,082.3 7.7 1,581.8 9.4....................... 21,927.2 100.0 28,997.3 100.0 35,745.1 100.0 14,017.7 100.0 16,845.7 100.0 114
115
116 20095311925 5 2 1 3 4 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 25 21 22 23 24 1 2 3 4 5 6 7 8 9 10 11 12 13 14 16 18 20 15 17 19 21 22 23 24 25 25 2010 5,00020,0003,00020,000
1231 531 2006 2007 2008 2008 2009 % % % % %................. 8,373.9 38.2 12,707.9 43.8 15,214.6 42.6 6,043.9 43.1 7,291.9 43.2................. 5,888.6 26.9 6,896.8 23.8 8,754.1 24.5 3,513.9 25.1 3,743.3 22.2................. 5,324.8 24.3 6,196.3 21.4 8,117.0 22.7 3,138.7 22.4 3,764.8 22.4................... 2,339.9 10.6 3,196.4 11.0 3,659.4 10.2 1,321.3 9.4 2,045.7 12.1....................... 21,927.2 100.0 28,997.3 100.0 35,745.1 100.0 14,017.7 100.0 16,845.7 100.0 20095314,7236702,545 22,000.................................. 1,218 388 7,652.................................. 782 313 3,961.................................. 880 557 6,191.................................... 1,843 1,287 4,351........................................ 4,723 2,545 22,155 20095311,651 256 1,395 117
(i)(ii) (iii) (iv) 118
36 2006200720081231200953136 674751 9023233.1% 2.6%2.5%1.9% 1231 2006 2007 2008 2009 531........................................ 327 148 102 267................................... (391) (703) (758) (725)........................... (64) (555) (656) (458)........................................ 4,214 3,659 3,003 2,545 119
30120 20062007200812 312009531362.2 468.4615.0271.2 50462009 53122,000 0.2%3,300 5030 Roche AstraZenecaPfizerGlaxoSmithKlineNovo NordiskMerck Eli Lilly100 95 90% 200953117,6004,300 120
162 (1) 4,400 3,300 3,200 600 1,100 2,000 500 130/0.4 700 D3 (1) 121
(1) 300 30R (II) 50R 1,000 900 A 700 200 30 100-2a-2a VIII (1) (1) 700 600 (1) 122
123
2003 180 124
GlaxoSmithKline Bayer Eli Lilly WMS RFIDRFID 5,00020,000 20072010 WMSCMS HIS 125
ERP WMS100,000 CMS GlaxoSmithKline Dainippon Sumitomo Pharmaceutical Co., Ltd 20081231 20095 31 632186 126
1231 2009 2006 2007 2008 531................ 187 89 276 184 88 272 170 76 246 196 78 274................ 53 112 165 68 115 183 76 56 132 81 58 139................ 86 14 100 87 14 101 83 7 90 80 8 88................ 44 0 44 51 0 51 37 0 37 41 0 41................ 5 0 5 6 0 6 30 33 63 43 34 77.................. 50 2 52 50 2 52 72 7 79 191 8 199.................. 425 217 642 446 219 665 468 179 647 632 186 818 2009 2006 1231 2007 2008 531........................................ 548 642 665 647 136 58 36 185............................... (42) (35) (54) (14)............................. 94 23 82 71........................................ 642 665 647 818 20082009 (i)20081159 (ii) 127
2009531632 2009531186 20062007200812312009531 11.610.915.3 3.9 (i) (ii)(iii) (iv)(v)(vi) 128
200953136144.1% 2319 90 160 129
2006 207 2006608 2007 332007 130
2010 (i)(ii)(iii) 20095315,2006,000 200940 50 SCRC BOTEK 131
FlukaFisher Scientific Hach 187 Fluka Sigma 1545 102 (i) 640(ii) 320 5004 132
138 25 2009531 292 133
.............. 53 (2:1)............ 4................ 9 C.............. 4.............. 24....... 4................ 3................ 10 (I).............. 26................ 1................ 25 134
2009531 219 1235 1545 135
20095311,935305 2010 2006200720081231 2009531 2.9%6.6%7.3%4.3% 136
20062007 200812312009531 20061231 20071231 20081231 2009531 (1) (2) (1) (2) (1) (2) (1) (2) (%) (%) (%) (%).. 80.0 109.9 137.4 (3) 200.0 116.9 58.5 200.0 149.0 74.5 100.8 91.5 90.8.. 100.0 98.1 98.1 500.0 175.4 35.1 500.0 289.3 57.9 208.3 214.9 103.2 (3)........... 20.0 19.4 97.0 30.0 16.7 55.7 30.0 17.2 57.3 12.5 5.1 40.6............. 1.3 (4) (4) 1.3 0.4 33.1 1.3 0.6 46.6 0.54 0.49 90.7.. 43.2 7.6 17.6 43.2 22.0 50.9 43.2 10.1 23.4 18.0 3.28 18.2......... 40.0 24.7 61.6 40.0 37.5 93.8 40.0 36.5 91.3 16.7 20.58 123.2......... 2.5 1.7 69.2 2.5 1.1 45.6 2.5 0.8 33.2 1.04 1.03 99.0......... 21.6 2.3 10.8 21.6 3.7 17.3 21.6 0.2 0.8 9.0 2.4 26.7............. 27.6 5.2 18.8 27.6 10.7 38.7 27.6 0.2 0.9 11.5 7.86 68.3.. 30.0 7.1 23.7 30.0 20.7 69.0 100.0 26.2 26.2 41.7 12.8 30.6.. 50.0 0.6 0.1 50.0 2.4 4.8 50 (5) (5)........... 80.0 10.5 13.1 80.0 36.9 46.1 136.0 109.7 80.7 66.7 37.8 56.7........... 30.0 (4) (4) 30.0 9.7 32.3 12.5 4.2 33.3......... 20.1 1.3 6.7 20.0 0.8 4.1 8.3 0.8 9.2 (1) 24300 24125 (2) (3) 100%300 (4) (5) 137
500 100 200920102011 81.7 2010 2009531 132.2 138
97,000 360720 2009531 20062007200812312009531 3.0%3.1%3.2%3.3% 1.0%1.0%1.1%0.9% 5.0% 20062007200812312009531 4,871.56,110.57,911.89,347.9 20062007200812312009531 25.022.410.9 17.7 139
7,900 20,00050,000 20062007200812312009 5311% 20062007200812312009531 12.3% 11.7%12.9%15.0% Roche 4.0%3.5%3.5% 3.9% 5% 3,300 3050 RocheNovo NordiskAstraZenecaPfizerBoehringer-IngelheimMerck Eli Lilly95100 1621,534 Boehringer-Ingelheim PfizerBayer Servier Bayer La Roche 140
Orchid Chemicals & Pharmaceuticals Ltd. 9,500 200820.0% 2008 10.8% 141
2001 2007340,000 142
2007ISO9001 (i)(ii) 143
ISO9001 ISO9001 2007 8 2006 144
20083 (i)(ii) (iii) 1296 24 32009 2006200720081231 200953116646 20095317438 20062007200812312009531 18.224.634.9 11.8 145
200881 ISOISO9000ISO14001 146
(i) (ii) (iii)(iv) (v) 3,6902009630 3530 2009630310254 562009630 611 2009630 810.6 147
200963035777,451 21589,139 66,593 121,718 21589,139 79,298 66,593 37,588 4,832 20101231 310425,100 254 148
376,79456 48,306 175250,016 4,916 74121,862 2528,895 242009375% 22 926 244.3 0.4 19,687 3119,410.59 149
562010 1231 3,411 200963016,003 10,421 2009630611190,699 474138,647 13752,053 474138,647 13752,053 (a) (b) (c) 106 (d) 150
2006200720081231200953110,572 11,05512,25914,4492009531............................................... 4,144 28.7.................................. 1,910 13.2.................................... 253 1.8.................................... 7,019 48.6 (1).............................................. 1,123 7.8............................................... 14,449 100.0 (1) 20062007200812312009531 562.7653.1891.8 327.4 151
(i)(ii)(iii) (i)(ii)(iii) (iv) (v) 145 110 152
20 153
154